BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37967443)

  • 1. Adverse Risks Associated With Proton Pump Inhibitors: A Systematic Review.
    Heidelbaugh JJ; Goldberg KL; Inadomi JM
    Gastroenterol Hepatol (N Y); 2009 Oct; 5(10):725-734. PubMed ID: 37967443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected].
    Heidelbaugh JJ; Goldberg KL; Inadomi JM
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S27-32. PubMed ID: 19262544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton Pump Inhibitors: Review of Emerging Concerns.
    Nehra AK; Alexander JA; Loftus CG; Nehra V
    Mayo Clin Proc; 2018 Feb; 93(2):240-246. PubMed ID: 29406201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overutilization of proton-pump inhibitors: what the clinician needs to know.
    Heidelbaugh JJ; Kim AH; Chang R; Walker PC
    Therap Adv Gastroenterol; 2012 Jul; 5(4):219-32. PubMed ID: 22778788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriate Use of Proton Pump Inhibitor Among Elderly Patients in British Columbia: What are the Long-term Adverse Events?
    Ben-Eltriki M; Chhabra M; Cassels A; Wright JM
    Curr Drug Saf; 2024; 19(2):244-247. PubMed ID: 37496243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence.
    Maes ML; Fixen DR; Linnebur SA
    Ther Adv Drug Saf; 2017 Sep; 8(9):273-297. PubMed ID: 28861211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting.
    Heidelbaugh JJ; Goldberg KL; Inadomi JM
    Am J Manag Care; 2010 Sep; 16(9):e228-34. PubMed ID: 21250399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome.
    Singh A; Cresci GA; Kirby DF
    Nutr Clin Pract; 2018 Oct; 33(5):614-624. PubMed ID: 30071147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitors: Understanding the associated risks and benefits of long-term use.
    Thurber KM; Otto AO; Stricker SL
    Am J Health Syst Pharm; 2023 Apr; 80(8):487-494. PubMed ID: 36629265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of the long-term use of proton pump inhibitors.
    Thomson AB; Sauve MD; Kassam N; Kamitakahara H
    World J Gastroenterol; 2010 May; 16(19):2323-30. PubMed ID: 20480516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
    Freedberg DE; Kim LS; Yang YX
    Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risks of long-term use of proton pump inhibitors: a critical review.
    Jaynes M; Kumar AB
    Ther Adv Drug Saf; 2019; 10():2042098618809927. PubMed ID: 31019676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications.
    Heidelbaugh JJ
    Ther Adv Drug Saf; 2013 Jun; 4(3):125-33. PubMed ID: 25083257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community-dwelling older adults' awareness of the inappropriate use of proton pump inhibitors.
    Rababa M; Rababa'h A
    BMC Geriatr; 2020 Oct; 20(1):431. PubMed ID: 33121444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis.
    Oshima T; Wu L; Li M; Fukui H; Watari J; Miwa H
    J Gastroenterol; 2018 Jan; 53(1):84-94. PubMed ID: 28744822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitor-associated pneumonia: Not a breath of fresh air after all?
    Fohl AL; Regal RE
    World J Gastrointest Pharmacol Ther; 2011 Jun; 2(3):17-26. PubMed ID: 21731913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse Event Reporting for Proton Pump Inhibitor Therapy: An Overview of Systematic Reviews.
    Abramowitz J; Thakkar P; Isa A; Truong A; Park C; Rosenfeld RM
    Otolaryngol Head Neck Surg; 2016 Oct; 155(4):547-54. PubMed ID: 27188706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential adverse effects of proton pump inhibitors.
    Coté GA; Howden CW
    Curr Gastroenterol Rep; 2008 Jun; 10(3):208-14. PubMed ID: 18625128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva.
    de la Coba Ortiz C; Argüelles Arias F; Martín de Argila de Prados C; Júdez Gutiérrez J; Linares Rodríguez A; Ortega Alonso A; Rodríguez de Santiago E; Rodríguez-Téllez M; Vera Mendoza MI; Aguilera Castro L; Álvarez Sánchez Á; Andrade Bellido RJ; Bao Pérez F; Castro Fernández M; Giganto Tomé F
    Rev Esp Enferm Dig; 2016 Apr; 108(4):207-24. PubMed ID: 27034082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.